Ear Fullness: What Could Be Causing It

Eustachian Tube Dysfunction: The Leading Cause

Eustachian tube dysfunction accounts for the majority of ear fullness complaints in primary care. The tube fails to equalize middle ear pressure, creating a sensation of blockage or muffled hearing that worsens during altitude changes, upper respiratory infections, or allergic flares.

The eustachian tube connects the middle ear to the nasopharynx and normally opens briefly during swallowing and yawning. When mucosal edema, adenoid hypertrophy, or poor muscular function prevents this opening, negative pressure develops in the middle ear space. Patients describe the feeling as identical to descending in an airplane that never "pops." A 2018 systematic review in The Laryngoscope found that the seven-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) reliably identifies ETD with a sensitivity of 100% and specificity of 100% against endoscopic findings when using a cutoff score of 14.5. Tympanometry showing a type C curve (negative middle ear pressure) or type B curve (flat tracing) supports the diagnosis objectively.

First-line treatment includes nasal corticosteroid sprays (fluticasone 50 mcg or mometasone 200 mcg daily), autoinflation using the Otovent balloon device, and treating underlying allergic rhinitis. A randomized controlled trial published in Clinical Otolaryngology demonstrated that autoinflation produced tympanometric resolution in 50% of children with otitis media with effusion at one month compared to 38% with watchful waiting. For refractory cases lasting beyond three months, balloon dilation of the eustachian tube has emerged as a safe intervention. The INFLATE trial reported in Clinical Otolaryngology showed sustained improvement in ETDQ-7 scores at 12 months post-procedure [1].

Cerumen Impaction

Cerumen impaction is the simplest cause of ear fullness and the easiest to treat. It affects approximately 6% of the general population and up to 57% of older adults in nursing facilities [2].

The ear canal produces cerumen as a protective, self-cleaning mechanism. Problems arise when cotton swabs, hearing aids, or earbuds push wax deeper into the canal, or when patients have narrow ear canals or excessive cerumen production. The American Academy of Otolaryngology-Head and Neck Surgery clinical practice guideline defines impaction as cerumen that causes symptoms or prevents examination of the tympanic membrane. Diagnosis requires direct visualization with an otoscope.

Treatment options include cerumenolytic drops (docusate sodium, hydrogen peroxide 3%, or carbamide peroxide), manual removal with a curette under direct visualization, or irrigation with body-temperature water. The AAO-HNS guideline specifically advises against irrigation in patients with tympanic membrane perforation or prior mastoid surgery [2]. Resolution is immediate upon removal. Patients who use hearing aids or have recurrent impaction benefit from prophylactic cerumenolytic drops every one to two weeks.

Middle Ear Effusion (Otitis Media with Effusion)

Fluid behind an intact tympanic membrane produces fullness, conductive hearing loss, and sometimes a sensation of fluid shifting. In adults, unilateral effusion persisting beyond six weeks demands nasopharyngeal examination to exclude malignancy.

Otitis media with effusion (OME) typically follows acute upper respiratory infection or acute otitis media. The fluid accumulates because the eustachian tube cannot drain secretions. Pneumatic otoscopy reveals decreased tympanic membrane mobility, and tympanometry shows a flat (type B) curve. A meta-analysis in The Cochrane Database of Systematic Reviews reported that 90% of post-acute OME episodes resolve within three months without intervention [3]. Antihistamines and decongestants have not demonstrated benefit over placebo in controlled trials.

When effusion persists beyond three months with associated hearing loss of 25 dB or greater, myringotomy with tympanostomy tube placement becomes the standard intervention. Tubes equalize pressure immediately and allow the middle ear mucosa to recover. In adults, any unilateral serous effusion lasting more than six weeks should prompt flexible nasopharyngoscopy to rule out nasopharyngeal carcinoma, particularly in patients of Southeast Asian descent or those with risk factors for Epstein-Barr virus-associated malignancies [4].

Ménière's Disease

Ménière's disease produces the classic tetrad of episodic vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness. The fullness often precedes vertigo attacks by hours or days, making it a useful warning sign for patients managing this condition.

The underlying pathology involves endolymphatic hydrops (excess fluid in the inner ear's endolymphatic space). Prevalence in the United States is approximately 190 to 200 per 100,000 adults according to data from the National Institute on Deafness and Other Communication Disorders. Diagnosis requires at least two spontaneous episodes of vertigo lasting 20 minutes to 12 hours, audiometrically documented low- to mid-frequency sensorineural hearing loss in the affected ear, and fluctuating aural symptoms (hearing, tinnitus, or fullness) in the affected ear, per the 2015 classification criteria jointly published by the Bárány Society and the American Academy of Otolaryngology [5].

Initial management follows a stepwise approach: sodium restriction to <2 to 000 mg daily, avoidance of caffeine and alcohol, and betahistine 16-48 mg daily (available outside the United States or through compounding pharmacies). The Cochrane review of betahistine for Ménière's found insufficient high-quality evidence to confirm or deny its effectiveness, though observational data and clinical experience support its use [6]. For patients who fail conservative measures, intratympanic dexamethasone injections reduce vertigo frequency in approximately 70-80% of cases based on retrospective series. Intratympanic gentamicin remains an option for refractory vertigo but carries a 10-30% risk of further hearing loss.

Superior Semicircular Canal Dehiscence (SSCD)

A bony defect in the superior semicircular canal creates a "third window" that alters inner ear fluid dynamics. Patients report fullness, autophony (hearing their own voice or eye movements), and sound-induced vertigo.

SSCD was first described by Lloyd Minor in 1998. CT temporal bone imaging with 0.5-mm cuts in the plane of the superior canal confirms the dehiscence. Vestibular evoked myogenic potentials (VEMPs) show reduced thresholds and elevated amplitudes on the affected side, providing a sensitive screening tool. A study in Otology & Neurotology demonstrated that cervical VEMP thresholds below 75 dB nHL have a sensitivity exceeding 90% for detecting SSCD [7]. CT prevalence of thinning or dehiscence is approximately 0.5-0.7% in radiographic studies, though many cases remain asymptomatic.

Surgical repair via middle fossa craniotomy with canal plugging or resurfacing eliminates symptoms in over 90% of patients when performed at experienced centers. Conservative management (avoiding triggers, using ear protection) suits patients with mild symptoms or those who decline surgery.

Temporomandibular Joint Disorders

The TMJ shares embryologic origins with the middle ear ossicles and sits millimeters from the anterior wall of the external auditory canal. Dysfunction produces referred aural symptoms in a substantial proportion of patients.

Estimates suggest that 10-30% of patients presenting with unexplained ear fullness have a TMJ component. A cross-sectional study in The Journal of Oral Rehabilitation found that patients with temporomandibular disorders reported aural fullness at rates three to four times higher than controls [8]. The mechanism likely involves tensor veli palatini muscle dysfunction (this muscle both opens the eustachian tube and stabilizes the mandibular condyle) and direct mechanical compression of the ear canal during jaw movement.

Diagnosis relies on clinical examination: tenderness over the TMJ or masticatory muscles, limited or deviated jaw opening, crepitus, and reproduction of ear symptoms with jaw maneuvers. Treatment includes soft diet, jaw physical therapy, occlusal splints, and NSAIDs. Most patients improve within six to eight weeks of conservative management.

Allergic and Non-Allergic Rhinitis

Chronic nasal inflammation produces eustachian tube mucosal edema that impairs middle ear ventilation. The fullness is bilateral, fluctuates with allergen exposure or seasons, and associates with nasal congestion and postnasal drip.

Allergic rhinitis affects 10-30% of adults worldwide according to World Health Organization estimates. The eustachian tube orifice sits in the nasopharynx where it is directly exposed to inflammatory mediators released during allergic responses. Intranasal corticosteroids remain the most effective single agent for managing ETD related to rhinitis. A double-blind trial published in The Annals of Otology, Rhinology & Laryngology showed that mometasone furoate nasal spray significantly improved tympanometric findings in adults with ETD compared to placebo over a six-week treatment period [9].

Second-generation antihistamines (cetirizine 10 mg, loratadine 10 mg, or fexofenadine 180 mg daily) address histamine-mediated symptoms but have limited direct effect on established effusion. Immunotherapy should be considered for patients whose ear symptoms correlate strongly with specific allergen exposure and do not respond to pharmacotherapy alone.

Sudden Sensorineural Hearing Loss

Ear fullness as the presenting complaint of sudden sensorineural hearing loss (SSNHL) is a diagnostic trap. Patients may not recognize mild hearing loss, reporting only fullness or "stuffiness" in one ear.

SSNHL affects 5-27 per 100,000 annually and is defined as a decline of 30 dB or greater over three contiguous frequencies occurring within 72 hours [10]. The American Academy of Otolaryngology clinical practice guideline emphasizes distinguishing sensorineural from conductive loss through tuning fork tests (Weber lateralizing to the unaffected ear, abnormal Rinne on the affected side) or urgent audiometry. Every patient presenting with acute unilateral ear fullness deserves at minimum a whisper test or finger-rub test at the bedside.

Treatment with high-dose oral corticosteroids (prednisone 1 mg/kg/day, maximum 60 mg, for 10-14 days) should begin within 14 days of onset for optimal recovery. Delay beyond two weeks significantly reduces salvage rates. Intratympanic dexamethasone serves as rescue therapy for patients who fail systemic steroids or have contraindications such as uncontrolled diabetes. MRI with gadolinium is recommended to exclude vestibular schwannoma, which presents as SSNHL in approximately 1-3% of cases [10].

Barotrauma and Patulous Eustachian Tube

Pressure-related ear fullness has two opposite mechanisms: failure of the tube to open (barotrauma) and failure of the tube to close (patulous ET). Both produce fullness, but their clinical contexts differ markedly.

Barotrauma occurs during rapid altitude changes (diving, flying) when the eustachian tube cannot equalize pressure. Middle ear pressure becomes negative relative to ambient, retracting the tympanic membrane. Severe cases produce hemotympanum or tympanic membrane rupture. Prevention with decongestants before flights (pseudoephedrine 60 mg one hour prior) and the Valsalva maneuver during descent remains standard advice. Divers should follow equalization protocols every 1-2 meters of descent.

Patulous eustachian tube is the opposite problem. The tube remains chronically open, transmitting respiratory sounds into the middle ear. Patients hear their own breathing and voice with disturbing loudness. Risk factors include significant weight loss (the peritubal fat pad thins), pregnancy, and dehydration. The condition is diagnosed by observing tympanic membrane excursion synchronous with nasal respiration during otoscopy. Initial management includes hydration, weight stabilization, and saline nasal drops. Severe cases may benefit from placement of a tympanostomy tube (which paradoxically helps by changing the impedance characteristics) or surgical techniques to bulk the tubal lumen [11].

Diagnostic Approach: A Practical Algorithm

The clinical evaluation of ear fullness requires systematic exclusion of serious pathology before attributing symptoms to benign ETD. Three elements guide initial assessment: laterality, associated symptoms, and duration.

Unilateral fullness demands more concern than bilateral. Associated vertigo suggests inner ear pathology (Ménière's, SSCD, perilymph fistula). Associated hearing loss requires audiometry within 48-72 hours to catch SSNHL within the treatment window. The minimum office evaluation includes otoscopy with pneumatic assessment, tuning fork tests (512 Hz), and tympanometry if available. "Dr. Jennifer Derebery of the House Ear Clinic has stated that any patient with unilateral aural fullness lasting more than two weeks and not clearly explained by cerumen or acute URI should undergo formal audiometry" [12].

Normal otoscopy with normal tympanometry and normal audiometry effectively rules out most structural causes and points toward ETD (with normal pressure), TMJ dysfunction, or myofascial tension. At that point, a trial of nasal steroids and jaw relaxation exercises for four weeks is reasonable before pursuing advanced imaging or vestibular testing.

When to Seek Urgent Evaluation

Certain combinations of symptoms transform ear fullness from a nuisance into a medical priority. Rapid recognition of these patterns prevents irreversible hearing loss or delays in diagnosing dangerous conditions.

Seek same-day evaluation for: unilateral fullness with acute hearing loss (SSNHL window is time-sensitive), fullness with severe vertigo and nystagmus (consider labyrinthitis, stroke if risk factors present), fullness with bloody otorrhea after trauma (temporal bone fracture), or fullness with facial nerve weakness (cholesteatoma, herpes zoster oticus). Urgent but not emergent referral applies to: unilateral fullness persisting more than four weeks, pulsatile tinnitus accompanying fullness (requires vascular imaging to exclude paraganglioma or dural fistula), and fullness with progressive sensorineural hearing loss over weeks to months (acoustic neuroma screening with MRI).

A retrospective review in The Journal of Laryngology & Otology found that 4.3% of adults referred for persistent unilateral ear fullness had a previously undiagnosed significant pathology, including two cases of nasopharyngeal carcinoma and one vestibular schwannoma in a cohort of 162 patients [13].